Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page
- Check4 days agoChange DetectedThe page shows a minor revision tag update from v3.3.3 to v3.3.4 that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a Locations section with Missouri as a site, and removed the Missouri Locations entry. The document revision was updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check55 days agoChange DetectedPublications section text now states that publications are automatically filled from PubMed, and the Revision tag has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedThe funding notice banner about government funding has been removed from the page. This does not alter the study details or related information presented.SummaryDifference0.4%

- Check77 days agoChange DetectedAdded institutional affiliations to the page: Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and Washington University School of Medicine. A Helpful Links Provided by section was also added to the page.SummaryDifference0.6%

- Check84 days agoChange DetectedRemoved sponsor/institution attributions for 'Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine' and 'Washington University School of Medicine', and the 'Helpful Links Provided by' section from the page.SummaryDifference0.2%

Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.